Table 4.
Effects of repeated EEM administration on glycogen and TG contents in liver and skeletal muscle of normal and diabetic mice.
| Group | Liver | Skeletal muscle | ||
|---|---|---|---|---|
| Glycogen (mg/g) | TG (μmol/g) | Glycogen (mg/g) | TG (μmol/g) | |
| Normal control | 12.43 ± 1.19 | 3.39 ± 0.28 | 1.66 ± 0.16 | 0.126 ± 0.009 |
| Normal + 2 g/kg EEM | 12.36 ± 1.05 | 3.45 ± 0.16 | 1.55 ± 0.14 | 0.123 ± 0.007 |
| Normal + 4 g/kg EEM | 12.67 ± 1.00 | 3.50 ± 0.25 | 1.72 ± 0.17 | 0.131 ± 0.011 |
| Normal + 8 g/kg EEM | 12.75 ± 1.33 | 3.35 ± 0.27 | 1.70 ± 0.15 | 0.131 ± 0.008 |
| Normal + glibenclamide | 12.81 ± 1.06 | 3.28 ± 0.26 | 1.71 ± 0.12 | 0.128 ± 0.007 |
| Diabetic control | 6.86 ± 0.41* | 5.28 ± 0.21* | 2.75 ± 0.20* | 0.226 ± 0.016* |
| Diabetic + 2 g/kg EEM | 7.28 ± 0.36 | 5.29 ± 0.34 | 2.75 ± 0.28 | 0.215 ± 0.019 |
| Diabetic + 4 g/kg EEM | 9.38 ± 1.14# | 4.24 ± 0.37# | 2.04 ± 0.22# | 0.170 ± 0.008# |
| Diabetic + 8 g/kg EEM | 9.79 ± 0.99# | 4.09 ± 0.30# | 2.03 ± 0.17# | 0.164 ± 0.011# |
| Diabetic + glibenclamide | 10.81 ± 0.77# | 5.15 ± 0.33 | 1.79 ± 0.13 # | 0.221 ± 0.020 |
Data are expressed as mean ± SD, n = 10 mice per group. *P < 0.01 when compared to normal control. # P < 0.01 when compared to diabetic control.